Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M328,086Revenue (TTM) $M70,877Net Margin (%)21.0Altman Z-Score5.3
Enterprise Value $M311,745EPS (TTM) $5.3Operating Margin %26.7Piotroski F-Score7
P/E(ttm)22.6Beneish M-Score-2.6Pre-tax Margin (%)25.5Higher ROA y-yN
Price/Book4.510-y EBITDA Growth Rate %4.2Quick Ratio2.7Cash flow > EarningsY
Price/Sales4.85-y EBITDA Growth Rate %5.9Current Ratio3.1Lower Leverage y-yN
Price/Free Cash Flow23.8y-y EBITDA Growth Rate %-9.2ROA % (ttm)11.0Higher Current Ratio y-yY
Dividend Yield %2.6PEG3.8ROE % (ttm)20.7Less Shares Outstanding y-yY
Payout Ratio %57.0Shares Outstanding M2,736ROIC % (ttm)28.2Gross Margin Increase y-yY

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JNJYacktman Focused Fund 2016-06-30 Reduce-0.87%$108.2 - $121.3
($113.54)
$ 119.926%Reduce -15.22%1,950,000
JNJTweedy Browne 2016-06-30 Reduce-0.5%$108.2 - $121.3
($113.54)
$ 119.926%Reduce -4.93%3,216,513
JNJBarrow, Hanley, Mewhinney & Strauss 2016-06-30 Reduce-0.35%$108.2 - $121.3
($113.54)
$ 119.926%Reduce -13.81%13,210,591
JNJDonald Yacktman 2016-06-30 Reduce-0.34%$108.2 - $121.3
($113.54)
$ 119.926%Reduce -5.78%6,671,349
JNJJoel Greenblatt 2016-06-30 Reduce-0.28%$108.2 - $121.3
($113.54)
$ 119.926%Reduce -97.97%4,906
JNJT Rowe Price Equity Income Fund 2016-06-30 Reduce-0.28%$108.2 - $121.3
($113.54)
$ 119.926%Reduce -14.17%3,400,000
JNJJohn Paulson 2016-06-30 Buy 0.16%$108.2 - $121.3
($113.54)
$ 119.926%New holding128,000
JNJRobert Olstein 2016-06-30 Reduce-0.13%$108.2 - $121.3
($113.54)
$ 119.926%Reduce -18.00%41,000
JNJFirst Eagle Investment 2016-06-30 Reduce-0.1%$108.2 - $121.3
($113.54)
$ 119.926%Reduce -33.52%759,790
JNJRichard Pzena 2016-06-30 Reduce-0.05%$108.2 - $121.3
($113.54)
$ 119.926%Reduce -6.94%1,103,032
JNJMario Gabelli 2016-06-30 Reduce-0.02%$108.2 - $121.3
($113.54)
$ 119.926%Reduce -7.33%312,831
JNJCharles Brandes 2016-06-30 Reduce-0.02%$108.2 - $121.3
($113.54)
$ 119.926%Reduce -8.97%133,128
JNJJohn Rogers 2016-06-30 Add0.01%$108.2 - $121.3
($113.54)
$ 119.926%Add 0.78%857,563
JNJRuane Cunniff 2016-06-30 Reduce$108.2 - $121.3
($113.54)
$ 119.926%Reduce -7.12%12,933
JNJKen Fisher 2016-06-30 Reduce$108.2 - $121.3
($113.54)
$ 119.926%Reduce -0.08%10,845,150
JNJDodge & Cox 2016-06-30 Add$108.2 - $121.3
($113.54)
$ 119.926%Add 1.08%35,185
JNJTweedy Browne 2016-03-31 Reduce-0.93%$95.75 - $109.14
($103.39)
$ 119.9216%Reduce -8.39%3,383,445
JNJFirst Eagle Investment 2016-03-31 Reduce-0.49%$95.75 - $109.14
($103.39)
$ 119.9216%Reduce -62.31%1,142,872
JNJYacktman Focused Fund 2016-03-31 Reduce-0.45%$95.75 - $109.14
($103.39)
$ 119.9216%Reduce -8.00%2,300,000
JNJT Rowe Price Equity Income Fund 2016-03-31 Reduce-0.33%$95.75 - $109.14
($103.39)
$ 119.9216%Reduce -15.23%3,961,300
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JNJ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Caruso Dominic JExec VP, Finance; CFO 2016-07-26Sell41,146$125.01-4.78view
Kapusta Ronald AController, CAO 2016-07-22Sell2,935$125.01-4.78view
Pruden Gary JExec VP, WW Chair, Med Devices 2016-06-07Sell9,735$116.032.59view
Kapusta Ronald AController, CAO 2016-06-07Sell3,000$115.792.81view
Kapusta Ronald AController, CAO 2016-05-10Sell3,957$114.773.72view
Stoffels PaulusChief Scientific Officer 2016-02-17Sell125,000$102.4316.22view
Fasolo PeterVP, Global Human Resources 2016-02-03Sell151,385$104.1214.33view
Ullmann Michael HVP, General Counsel 2015-11-20Sell17,650$102.4716.17view
Caruso Dominic JVP, Finance; CFO 2015-11-02Sell20,569$102.2116.47view
Kapusta Ronald AController, CAO 2015-10-23Sell6,239$99.6819.42view

Press Releases about JNJ :

Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    Can Novartis Tide Over the Alcon Crisis? Aug 26 2016 
    Tight Trading on Thursday with Stocks Ending Lower Aug 25 2016 
    Healthcare Drug Pricing a Factor for the Market on Wednesday Aug 24 2016 
    Merck Offers Value and Steady Dividend Growth Aug 24 2016 
    U.S. Stocks Trading Lower with Market Uncertainty Aug 22 2016 
    US Stocks Higher after July FOMC Minutes Aug 17 2016 
    Johnson & Johnson Is Currently Overvalued Aug 17 2016 
    U.S. Market Indexes Lower on Tuesday Aug 16 2016 
    Novartis Needs to Stem the Bleeding From Gleevec Decline Aug 16 2016 
    Ray Dalio's 5 Biggest 2nd-Quarter New Stock Buys Aug 11 2016 

    More From Other Websites
    Famed Short Seller Jim Chanos’ Was Bullish On These Stocks in Q2 Aug 28 2016
    Proof that you can't afford to ignore the power of dividends Aug 28 2016
    5 Stocks With Rising Dividends for 50 Years in a Row Aug 26 2016
    7 Healthcare Dividend Stocks for Quality and Security Aug 26 2016
    After Jackson Hole - The Four Most Important Investment Issues Aug 26 2016
    Johnson & Johnson to Participate in the 2016 Wells Fargo 11th Annual Healthcare Conference Aug 25 2016
    Merck Offers Value and Steady Dividend Growth Aug 24 2016
    How MAKO Robots Could Contribute to SYK’s Orthopedics Growth Aug 24 2016
    10 Stocks Billionaire John Paulson Is Buying for 2016 Aug 24 2016
    J&J (JNJ) Seeks EU Approval for Darzalex's Expanded Use Aug 24 2016
    [$$] MPs call for ban on microbeads in toiletries Aug 23 2016
    U.S. Stocks Trading Lower with Market Uncertainty Aug 22 2016
    S&P 500, Dow industrials book a loss as oil snaps win streak Aug 22 2016
    Apple, J&J Weigh on DJIA Monday Aug 22 2016
    McDonald's, Verizon And 3 Others That May Drag Down The Dow Aug 22 2016
    [$$] Two Strategies, One Crowded Trade Aug 21 2016
    How Does Bristol-Myers Squibb’s Valuation Compare to Peers? Aug 19 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)